A rare pancreatic neuroendocrine tumor with proinsulin-secreting activity
https://doi.org/10.14341/serg12342
Abstract
This paper presents a clinical case describing hypoglycemic condition with atypical symptoms in a young patient in the early postpartum period. Abdominal ultrasound revealed a large formation in the hook region of the pancreas, which was subsequently confirmed according to endoscopic ultrasound, CT and MRI. The idea of insulinoma was formed according to the presence of pancreatic formation, documented Whipple’s triad, and data on hyperinsulinism at the outpatient stage. However, the 72-hour fasting test showed no significant increase in insulin and C-peptide levels. After excluding other causes of hypoglycemia, the patient was suspected of having proinsulinoma, which was confirmed by increased blood proinsulin level. Gastropancreatoduodenal resection was performed. We detected a highly differentiated neuroendocrine pancreatic tumor with the expression of CD56, NSE, synaptophysin and chromogranin A, with a Ki-67 index of about 1%. After surgical treatment, hypoglycemic conditions were not observed.
About the Authors
Anna R. VolkovaRussian Federation
MD, PhD, Professor
Svetlana V. Dora
Russian Federation
MD, PhD
Elena N. Ostrouchova
Russian Federation
MD, PhD
Anna V. Lisker
Russian Federation
MD
Galina V. Semikova
Russian Federation
MD
Ekateryna U. Demydenko
Russian Federation
medical resident
References
1. Beltsevich DG. ENETS consensus guidelines for the management of patients with digestive neuroendocrine neoplasms of the digestive system. Endocrine Surgery. 2012;6(3):8–40. (In Russ.). doi: https://doi.org/10.14341/2306-3513-2012-3-8-40
2. Murtha TD, Lupsa BC, Majumdar S, et al. A Systematic Review of Proinsulin-Secreting Pancreatic Neuroendocrine Tumors. J Gastrointest Surg. 2017;21(8):1335-1341. doi: https://doi.org/10.1007/s11605-017-3428-8
3. de Herder WW, Niederle B, Scoazec J-Y, et al. Well-Differentiated Pancreatic Tumor/Carcinoma: Insulinoma. Neuroendocrinology. 2006;84(3):183-188. doi: https://doi.org/10.1159/000098010
4. Piovesan A, Pia A, Visconti G, et al. Proinsulin-secreting neuroendocrine tumor of the pancreas. J Endocrinol Invest. 2003;26(8):758-761. doi: https://doi.org/10.1007/BF03347360
5. Gama R, Marks V, Wrlght J, Teale JD. Octreotide exacerbated fasting hypoglycaemia in a patient with a proinsulinoma; the glucostatic importance of pancreatic glucagon. Clin Endocrinol (Oxf ). 1995;43(1):117-120. doi: https://doi.org/10.1111/j.1365-2265.1995.tb01901.x
6. Cryer PE, Axelrod L, Grossman AB, et al. Evaluation and Management of Adult Hypoglycemic Disorders: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2009;94(3):709-728. doi: https://doi.org/10.1210/jc.2008-1410
7. Yukina MY, Nuralieva NF, Troshina EA, et al. The hypoglycemic syndrome (insulinoma): pathogenesis, etiology, laboratory diagnosis (review, part 1). Problems of Endocrinology. 2017;63(4):245–256. (In Russ.). doi: https://doi.org/10.14341/probl2017634245-256
8. Volkova NI, Porksheyan MI, Kanayeva MA, et al. Clinical case of rare neuroendocrine tumor of pancreas — proinsulinoma. Endocrine surgery. 2015;9(4):26–31. (In Russ.). doi: https://doi.org/10.14341/serg2015426-31.
Supplementary files
|
1. Figure 1. Ultrasound examination of the abdominal organs with formation in the pancreas. | |
Subject | ||
Type | Исследовательские инструменты | |
View
(207KB)
|
Indexing metadata ▾ |
|
2. Figure 2. MRI of the abdominal organs with contrast enhancement. Arrows show the formation in the pancreas. | |
Subject | ||
Type | Исследовательские инструменты | |
View
(171KB)
|
Indexing metadata ▾ |
Review
For citations:
Volkova A.R., Dora S.V., Ostrouchova E.N., Lisker A.V., Semikova G.V., Demydenko E.U. A rare pancreatic neuroendocrine tumor with proinsulin-secreting activity. Endocrine Surgery. 2020;14(2):16-20. (In Russ.) https://doi.org/10.14341/serg12342

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND 4.0).